The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Clinical · Comorbidities · continued

Hypertension improvement and when medication needs revisiting — a second dataset posts 121–134

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

VM
v.malinowskiTL228 Oct 2024#121
VS
vial_slopeTL3Regular28 Oct 2024#122
KLindqvist, post #26: A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied. Go to post

Post #119 is right about the mechanism and I think understates the practical bit.

Where two conditions pull in opposite directions, that is a clinical judgement rather than a lookup, and it is the kind of question a forum answers worst.

Two sources, same conclusion, and I could not rule out that one copied the other.

0 likes in reply to #26 21mo
NH
n.hartmannTL228 Oct 2024#123

Noted, and thank you for writing it out rather than summarising it.

20 likes 21mo
LP
l.parkinsonTL2Member29 Oct 2024 · edited#124

The version of Hypertension improvement that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those conditions are where the interesting cases live.

8 likes 21mo
MN
ma.nascimentoTL229 Oct 2024#125
septum_entry, post #42: Post #38 and I disagree about the size of the effect, not about the direction. A definition problem is doing most of the work in this Hypertension improvement discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is small. Go to post

I had written a reply contradicting post #124 and deleted it. Here is what survived.

Taking Hypertension improvement seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two things support very different sentences.

0 likes in reply to #42 21mo
CP
citation_peakTL3Regular29 Oct 2024#126

Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it.

0 likes 21mo
FY
f.yildizTL229 Oct 2024#127

Agreed on Hypertension improvement, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the starting assumption is the part nobody states.

14 likes 21mo
W
WendelboeTL2Member29 Oct 2024#128

Marking my uncertainty on Hypertension improvement explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises past the case in the first post.

5 likes 21mo
AV
ai.vukovicTL229 Oct 2024 · edited#129

Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public.

8 likes 21mo
ER
eire_readerTL229 Oct 2024#130
FR
f.rasmussenTL230 Oct 2024#131

Hypertension improvement: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.

5 likes 21mo
PR
policy_readerTL2Regular30 Oct 2024#132

The reason Hypertension improvement is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.

14 likes 21mo
EA
e.adeyemiTL230 Oct 2024#133

The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about.

I would be interested in a counterexample if anyone has one.

0 likes 21mo
GT
g.tanakaTL3Regular30 Oct 2024#134
v.bergstrom, post #67: Eating-disorder history is raised here regularly and is the case where the guidance most consistently says the decision needs specialist input. Small point, but it is the one that usually catches people. Go to post

Post #132 describes the usual case. This is about the unusual one.

Two sentences on Hypertension improvement and then I will stop, because the rest is speculation and the thread is better without mine.

What is documented is narrow. What is inferred from it is broad. The gap between them is where every argument here lives.

0 likes in reply to #67 21mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Hepatic steatosis: what the MASH trial evidence supports — one year on
On the subject in the title: Hepatic steatosis: what the MASH trial evidence supports — one year on Working notes rather than a conclusion. Reading back through what has been written here about Hepatic…
VVSMG 2 4.1k 6mo
Revisiting: PCOS and metabolic overlap: what is and is not studied
Revisiting: PCOS and metabolic overlap: what is and is not studied — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on PCOS and metabolic…
FEMHRSOBKD+55 59 26k 2d
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class — setting out what I have, and where I think it stops being reliable. Something about Obstructive sleep apnoea does not reconcile and…
SVCLRF 2 726 14mo
PCOS and metabolic overlap: what is and is not studied
On the subject in the title: PCOS and metabolic overlap: what is and is not studied Working notes rather than a conclusion. PCOS and metabolic overlap, from the point of view of someone who has read the…
SGPGBST 3 6.6k 1d
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Trying to work out what would count…
NANKEML+18 25 1.7k 22mo

Related topics — sharing the tags blood pressure, type 2 diabetes, obstructive sleep apnoea

TopicParticipantsRepliesViewsActivity
Type 2 diabetes and the largest part of the evidence base
Posting this under the heading it deserves: Type 2 diabetes and the largest part of the evidence base Everything below is what sits behind that. Trying to work out what would count as evidence on type 2…
CNFNAISCJB+81 89 2.9k 3mo
[2026 update] Cardiovascular risk: reading the outcome trials as a set
Posting this under the heading it deserves: Cardiovascular risk: reading the outcome trials as a set Everything below is what sits behind that. I have spent a fortnight trying to pin Cardiovascular risk down…
SOAWKRLDNL+99 103 32k 11mo
Revisiting: Gallbladder disease risk with rapid weight loss
Revisiting: Gallbladder disease risk with rapid weight loss Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers on…
BVSLN 2 2k 9mo
Heart failure with preserved ejection fraction: symptom endpoints
Heart failure with preserved ejection fraction: symptom endpoints — setting out what I have, and where I think it stops being reliable. Heart failure with preserved ejection keeps being re-asked here and I…
ITSGSRFVII+19 23 311 12d
How to ask for a dose change without antagonising anyone — what changed since
How to ask for a dose change without antagonising anyone — what changed since — that is the question, and I have not found it answered plainly anywhere I have looked. A question about how to describe…
RVHKTDESAA+81 92 10k 20mo